Beta VigiAMS™ is currently in closed beta with select pilot hospitals — not yet generally available. Apply for the pilot →
Closed beta · v0.9 — ICMR AMSP aligned

Antimicrobial Stewardship,
Simplified for Indian Hospitals.

ICMR-aligned AMSP software covering antibiogram, DDD/DOT usage tracking, restricted-drug approvals, prophylaxis audits, and HAI surveillance. Web dashboard with Android and iOS apps in private beta.

Built on ICMR AMSP guidelines CLSI M39 & M100 compliant WHO AWaRe categorization
app.vigiams.in / dashboard
LIVE
MDRO Rate
0%
↓ 0.8 vs Q1
Pending Approvals
0
3 over 48h
DDD / 1000 PD
0
+12 MoM
WHO AWaRe — consumption Target: Access ≥ 60%
Access 61.4 Watch 30.2 Reserve 8.4
Facility Antibiogram · CLSI M39 Q2 2026 · n=274
CLABSI
0 /1k device-days
CAUTI
0 /1k device-days
VAP
0 /1k device-days
The problem

Antimicrobial resistance is India's silent crisis. Most hospitals still track stewardship in spreadsheets, miss outbreak signals, and can't generate a CLSI-compliant antibiogram on demand. VigiAMS fixes that.

Modules

Eight pillars. One platform.

Every ICMR AMSP requirement, available out of the box — and integrated end-to-end.

Platforms

Built for the committee. Built for the bedside.

Web Dashboard

For the AMS Committee.

Full management console — bulk culture imports, antibiogram editor, restricted-drug list governance, audit reports, and one-click ICMR/NABH exports.

  • Bulk import from CSV / Excel / HL7
  • Antibiogram builder with MDRO flags
  • Committee approvals + audit trail
  • Exportable NABH-ready reports
Committee · Q2 2026
Approvals queue
7
Antibiogram
Q2 ✓
DUE audits — last 30 days
Mobile App · iOS & Android

For the ward clinician.

Approvals, audits and dashboards in your pocket. Submit a restricted-drug request from rounds; receive committee feedback within minutes.

  • One-tap approval requests with culture context
  • Push notifications for approval decisions and follow-up reminders
  • Bedside DUE audit forms
  • Biometric login, offline-capable
09:425G ▰▰▰
Today
Approvals
Pending12m ago
Meropenem 1g q8h
Bed 14 · ICU-2 · Dr. Shah
Review1h ago
Colistin 9MU/day
Bed 03 · ICU-1 · Dr. Rao
Approved3h ago
Vancomycin 1g q12h
Bed 22 · MW · Dr. Iyer
Outbreak2h ago
CRE cluster · ICU-2
3 isolates in 5 days
ApprovalsAuditsDashboardMore
Compliance & Standards

Every metric maps to a published standard.

ICMR AMSP
All 8 pillars
CLSI M39
Antibiogram
CLSI M100
Susceptibility
WHO AWaRe
Access · Watch · Reserve
NABH
Aligned
ABDM
Ready
How it works

From culture log to ICMR report — in four steps.

  1. 01

    Connect your data

    Connect your LIS or upload culture data via CSV, Excel or HL7.

  2. 02

    Auto-generate

    Facility antibiogram + AWaRe metrics computed against the standard.

  3. 03

    Workflows go live

    Approvals, audits, surveillance and outbreak alerts switch on.

  4. 04

    Export reports

    ICMR / NABH-ready reports exported in one click.

Why VigiAMS

Engineered for Indian tertiary care.

Built for India.

ICMR-aligned out of the box. AWaRe-mapped Indian formulary. Supports tertiary-care nuances and multi-facility chains.

Every pillar, one platform.

Replaces 4–5 spreadsheets and standalone tools. One source of truth across microbiology, pharmacy and committee.

Clinician-friendly mobile.

Approvals and audits don't need a desktop. Submit, review and act from the ward in seconds.

What's next

The platform keeps growing.

Three major capabilities are in active development with our pilot hospitals.

Coming soon

Complete HIC management

Full Hospital Infection Control suite — surveillance bundles, isolation precautions, hand-hygiene audits and outbreak workflows, end to end.

Coming soon

AI clinical decision support

Antimicrobial recommendations grounded in your own antibiogram, culture context and stewardship guidelines — at the point of prescribing.

Coming soon

AI-based studies

Automated stewardship research — point-prevalence studies, DUE analyses and outcome trends generated from your hospital's own data.

Security & deployment

Data sovereign. Audit-ready.

Azure Central India (Pune)
Patient data stays in India.
Encrypted at rest + in transit
TLS everywhere; AES-256 at rest.
Role-based access
Validated at every endpoint.
Complete audit logs
Every read & write recorded.
Pricing

Simple during beta.

We're partnering with a small number of hospitals for the closed beta. Public pricing will be announced at general availability.

Closed beta · Pilot program

Pilot partners get the full platform.

Pilot terms are agreed per hospital — no public rate card yet. Every pilot includes:

  • All eight AMSP modules — nothing gated
  • Web dashboard + iOS & Android apps
  • Guided onboarding + antibiogram baseline
  • Priority support during the pilot
  • Your feedback shapes the roadmap
  • Export your data anytime — no lock-in
Apply for the pilot Limited pilot slots · No credit card required
Request a demo

See VigiAMS running on your hospital's data — in 30 minutes.

No credit card. We walk you through your antibiogram, AWaRe split and approvals queue with real data from our pilot setup.

  • Focused walkthrough covering your AMSP use case — not a generic product tour
  • Covers antibiogram, DDD/DOT, approvals workflow, and HAI dashboards
  • Response within one business day

Request a Demo

Fill in the form and we'll be in touch within one business day.

Request received

We'll reach out within one business day to schedule your demo.

FAQ

Common questions.